Brussels, 20/04/2001 (Agence Europe) - The European Federation of Pharmaceutical Industries and Associations (EFPIA) welcomed the agreement that arose on Thursday between the South African government and the forty-odd laboratories part of the court case aiming to prevent the enforcement of a law passed, according to them, in violations of the international rules protecting intellectual property (TRIPS agreement).
In a press release, the Director General of the EFPIA, Brian Ager, stated: "We...